Kyntra Bio KYNB
NASDAQ KYNB
$3.13 -0.36 (-10.39%)
As of: Nov 16, 2026 · 3:11 PM EST

Kyntra Bio (KYNB) Preferred Shares (2012 - 2013)

Updated

Analysis

Kyntra Bio (KYNB) Preferred Shares (2012 - 2013) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,280.93 Bn 1,254.54 Bn 20.46 Bn -
2 Johnson & Johnson 682.37 Bn 602.24 Bn 17.30 Bn -
3 AbbVie 521.21 Bn 489.22 Bn 13.12 Bn -
4 Merck 359.54 Bn 322.48 Bn 13.19 Bn -
5 Novartis Ag 311.67 Bn 284.91 Bn - -
6 Astrazeneca 285.23 Bn 258.88 Bn 13.26 Bn -
7 Amgen 250.91 Bn 202.56 Bn 7.58 Bn -
8 Gilead Sciences 208.44 Bn 183.55 Bn 6.73 Bn -
9 Pfizer 164.84 Bn 112.20 Bn 12.56 Bn -
10 Kyntra Bio 12.57 Mn -395.37 Mn 1.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 168.44 Mn
Dec 31, 2012 168.44 Mn
API Access

Kyntra Bio Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=KYNB&period=max&api_key=YOUR_API_KEY